Defunct Company
Total Trials
20
As Lead Sponsor
17
As Collaborator
3
Total Enrollment
4,139
NCT00069745
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2003
Completion: Mar 31, 2007
NCT00093132
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy
Phase: Phase 1/2
Start: Aug 31, 2004
Completion: Feb 28, 2009
NCT00095186
Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
Phase: Phase 2
Start: Sep 30, 2004
NCT00265655
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Start: Nov 30, 2005
Completion: Feb 29, 2008
NCT00268970
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Start: Dec 31, 2005
Completion: Sep 30, 2009
NCT00313456
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
Phase: Phase 1
Start: Mar 31, 2006
Completion: Mar 31, 2009
NCT00329329
Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies
Start: May 31, 2006
NCT00370383
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Start: Jul 31, 2006
NCT00450970
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
Start: Feb 28, 2007
Completion: Dec 31, 2009
NCT00125411
Study of Satraplatin (JM-216) in Combination With Docetaxel
Start: Mar 31, 2007
NCT00480623
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Start: May 31, 2007
Completion: Apr 30, 2008
NCT00473720
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Role: Collaborator
Completion: Jun 30, 2010
NCT01220284
Satraplatin and Vinorelbine in Advanced Solid Tumors
Start: Feb 29, 2008
Completion: Feb 28, 2011
NCT00630656
Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Start: Apr 30, 2008
Completion: Feb 28, 2010
NCT00707304
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Start: Nov 30, 2008
Completion: Aug 31, 2012
NCT00706862
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Start: Feb 28, 2009
Completion: Mar 31, 2016
NCT00854633
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Start: Jun 30, 2009
Completion: Dec 31, 2012
NCT01273779
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Phase: Phase 2/3
Start: Jun 30, 2011
Completion: Dec 31, 2014
NCT01168882
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies
Start: Nov 30, 2011
Completion: Jul 31, 2015
NCT01528137
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Start: May 31, 2012
Completion: Jul 31, 2013